Gastrectomy | Ricerc@Sapienza

Enhanced recovery after surgery for gastric cancer (ERAS-GC). Optimizing patient outcome

Significant advances were achieved, in last decades, in the management of surgical patients with gastric cancer. This has led to the concept of enhanced recovery after surgery (ERAS) with the objective of reducing the length of hospital stay, accelerating postoperative recovery and reducing the surgical stress. The ERAS protocols have many items, including the pre-operative patient education, early mobilization and feeding starting from the first postoperative day.

Elevated gastric juice carbohydrate antigen 72.4 (Ca 72.4) is an independent prognostic factor of poor survival for gastric cancer patients

Background/aim: As of 2020, carbohydrate antigen 72.4 (Ca 72.4) has been rarely investigated in the gastric juice (GJ) of patients with gastric cancer (GC). Our aim was to analyze the significance and role of this tumor antigen in the GJ of our GC population.
Patients and methods: Between April 2012 and July 2013, 37 patients with operable GC were prospectively investigated to determine the GJ Ca 72.4 levels before surgical manipulation.

Complications after laparoscopic sleeve gastrectomy: can we approach a 0% rate using the largest staple height with reinforcement all along the staple line? short-term results and technical considerations

Background: Laparoscopic sleeve gastrectomy (SG) is gaining acceptance among bariatric surgeons as a viable option for treating morbidly obese patients. We describe the results of a single center's experience with SG, revealing a low complication rate. Objectives: The aim of the study was to analyze the short-term results of laparoscopic SG using exclusively black staples with staple-line reinforcement. Settings: University hospital, tertiary referral center for bariatric surgery. Methods: SG was performed in 434 consecutive patients from December 2014 to March 2017.